Metaclazepam
From Drugwiki
Metaclazepam is a benzodiazepine derivative. It is a relatively selective anxiolytic with less sedative or muscle relaxant properties than other benzodiazepines such as diazepam or bromazepam.
| |
Metaclazepam
| |
| Systematic (IUPAC) name | |
| 7-bromo-5-(2-chlorophenyl)-2-(methoxymethyl)-1-methyl-2,3-dihydro-1H-1,4-benzodiazepine | |
| Identifiers | |
| CAS number | |
| ATC code | ? |
| PubChem | |
| Chemical data | |
| Formula | C18H18BrClN2O |
| Mol. mass | 393.705 |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Metaclazepam is slightly more effective as an anxiolytic than bromazepam, or diazepam, with a 15mg dose of metaclazepam equivalent to 4mg of bromazepam.
